NXERA PHARMA CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,468 JPY | +0.69% |
|
+0.07% | +3.31% |
| 04-18 | Nxera Pharma Initiates Restricted Stock Unit Plans, Starting with Shares Worth 164 Million Yen in Total in May | MT |
| 04-17 | Nxera Pharma's Neuro Drug NBI-1117568 Passed Preclinical Toxicity Test | MT |
Chart calendar Nxera Pharma Co., Ltd.
2dedbc7b8928e1ef799d002f6f.-SdObFT7KHFOkd_0YxmsXKRCgYQgBV_zgmiTBvPZV_g.kwoID3mLX0QI6em6VUz7Os9xzOENbDe_0S78TayND5WaaSRZBaMfFxrOng~6a0bf2ac45bc7176fd85a295340bbaa7
Upcoming events on Nxera Pharma Co., Ltd.
Past events on Nxera Pharma Co., Ltd.
| 27/03/2024 01:00 | Annual General Meeting |
| 13/02/2024 08:00 | Q4 2023 Earnings Call |
| 13/02/2024 06:30 | Q4 2023 Earnings Release |
| 10/01/2024 21:30 | JPMorgan Healthcare Conference |
| 14/11/2023 10:30 | Jefferies London Healthcare Conference |
| 11/11/2023 21:30 | J.P. Morgan Healthcare Conference |
| 10/11/2023 07:07 | Q3 2023 Earnings Release |
| 10/11/2023 07:00 | R&D Day |
| 04/08/2023 09:00 | Q2 2023 Earnings Call |
| 03/08/2023 | Q2 2023 Earnings Release |
| 20/07/2023 09:00 | Acquisition of Idorsia Pharmaceutical Ltd By Sosei Group Corp Call |
| 12/05/2023 07:30 | Q1 2023 Earnings Release |
| 23/03/2023 01:00 | Annual General Meeting |
| 14/02/2023 08:00 | FY 2022 Earnings Call |
| 14/02/2023 06:30 | FY 2022 Earnings Release |
| 11/01/2023 21:30 | J.P. Morgan Healthcare Conference |
| 15/11/2022 11:30 | Jefferies London Healthcare Conference |
| 11/11/2022 06:44 | Q3 2022 Earnings Release |
| 13/10/2022 07:30 | R&D Day |
| 10/08/2022 09:00 | Interim 2022 Earnings Call |
Past dividends on Nxera Pharma Co., Ltd.
| 26/03/2015 | Bonus Payment 10 JPY |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 9 726 8 894 9.36% | 8 842 9 821 -9.97% | 17 712 16 418 7.88% | 15 569 15 096 3.13% | 12 766 16 328 -21.81% | 35 223 |
|
EBITDA Million JPY | Released Forecast Spread | 1 873 4 930 -62.01% | 2 278 2 389 -4.66% | 5 053 7 040 -28.22% | 4 781 1 629 193.55% | -7 048 -5 290 -33.23% | 4 185 |
|
EBIT Million JPY | Released Forecast Spread | 384 1 851 -79.25% | 928 1 395 -33.48% | 3 775 6 308 -40.15% | 3 436 2 635 30.41% | -9 526 -5 364 -77.59% | 3 754 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 534 4 704 -88.65% | 1 622 2 398 -32.36% | 433 6 887 -93.71% | 1 078 1 975 -45.41% | -10 680 -7 618 -40.2% | 2 587 |
|
Net income Million JPY | Released Forecast Spread | 1 432 2 419 -40.81% | 1 479 1 244 18.85% | 475 5 519 -91.39% | 382 1 854 -79.4% | -7 913 -2 898 -173.08% | 951 |
|
EPS JPY | Released Forecast Spread | 18,7 34,9 -46.36% | 18,8 11,8 59.64% | 5,86 68,6 -91.46% | 4,68 22,7 -79.43% | -87,2 -75,5 -15.47% | 22,4 |
| Announcement Date | 13/02/20 | 12/02/21 | 10/02/22 | 14/02/23 | 13/02/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2021 S1 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 4 670 10 204 -54.23% | 2 516 | 3 123 3 155 -1.01% | 14 122 12 640 11.72% | 14 589 13 107 11.31% | 1 119 1 060 5.57% | 1 338 1 220 9.67% | 2 457 | 6 184 5 400 14.52% | 6 928 5 399 28.32% | 13 112 11 583 13.2% | 943 | 2 146 | 3 328 7 000 -52.46% | 7 292 13 254 -44.98% | 11 300 | 6 000 | 6 700 | 14 100 |
|
EBITDA Million JPY | Released Forecast Spread | 2 300 | -4 100 | -4 500 | 6 700 | |||||||||||||||
|
EBIT Million JPY | Released Forecast Spread | -347 5 461 -106.35% | -1 136 | -1 849 -996 -85.64% | 8 043 8 917 -9.8% | 5 624 6 539 -13.99% | -2 206 -1 640 -34.51% | -3 804 | 3 189 | 4 051 1 565 158.85% | 7 240 4 754 52.29% | -1 964 | -4 168 | -3 554 3 390 -204.84% | -1 534 5 148 -129.8% | 2 300 | -4 100 | -4 500 | 6 700 | |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 242 5 600 -95.68% | -1 270 | -1 393 -996 -39.86% | 4 585 9 789 -53.16% | 1 826 7 030 -74.03% | -2 497 -1 640 -52.26% | -4 282 | 1 174 | 4 186 2 122 97.27% | 5 360 3 296 62.62% | -1 863 | -3 760 | -4 105 3 490 -217.62% | -2 815 1 619 -273.87% | 2 250 | -4 150 | -4 550 | 6 650 | |
|
Net income Million JPY | Released Forecast Spread | 1 037 4 700 -77.94% | -2 117 | -2 297 -996 -130.62% | 2 300 6 628 -65.3% | 2 772 7 100 -60.96% | -2 070 -1 691 -22.41% | -3 538 | 313 | 3 607 2 925 23.32% | 3 920 3 238 21.06% | -1 402 | -2 060 | -4 925 2 490 -297.79% | -928 1 070 -186.73% | 2 950 | -5 550 | -6 050 | 8 950 | |
|
EPS JPY | Released Forecast Spread | -27,5 | -28,4 | -25,4 | -43,3 | 3,87 | -17,1 | -25,1 | -59,9 30,7 -295.37% | -2,13 13,2 -116.16% | 18,9 | -32,6 | -35,7 | 55,2 | ||||||
| Announcement Date | 13/02/20 | 13/08/20 | 12/08/21 | 10/02/22 | 10/02/22 | 13/05/22 | 10/08/22 | 10/08/22 | 11/11/22 | 14/02/23 | 14/02/23 | 12/05/23 | 04/08/23 | 10/11/23 | 13/02/24 | - | - | - | - |
More events
Past sector events for Nxera Pharma Co., Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4565 Stock
- Calendar Nxera Pharma Co., Ltd.
